ASAM

MCG Releases 28th Edition of Guidelines with New Support for the 2024 Medicare Advantage Final Rule

Retrieved on: 
Tuesday, February 27, 2024

SEATTLE, Feb. 27, 2024 /PRNewswire-PRWeb/ -- MCG Health, part of the Hearst Health network and an industry leader in technology-enabled evidence-based guidance, announces the release of its 28th edition of the MCG care guidelines. Many new changes to the industry-leading guidelines were made to help payers and providers support compliance with the 2024 Medicare Advantage and Part D Final Rule (CMS-4201-F) which was announced by the Centers for Medicare & Medicaid Services (CMS) in April 2023.

Key Points: 
  • Many new changes to the industry-leading guidelines were made to help payers and providers support compliance with the 2024 Medicare Advantage and Part D Final Rule (CMS-4201-F) which was announced by the Centers for Medicare & Medicaid Services (CMS) in April 2023.
  • - Jon Shreve, President & CEO, MCG Health
    MCG care guidelines are among the most widely used clinical guidelines in the healthcare industry.
  • The updates were designed to help payers and providers support compliance with the 2024 Medicare Advantage and Part D Final Rule (CMS-4201-F).
  • In addition, MCG will hold several educational sessions related to the 28th edition at their annual Client Forum in Phoenix, Arizona (April 22-24).

NIDA Director to Deliver Keynote; Innovative Toxicology Research to Feature at 2024 ACMT Annual Scientific Meeting and Symposia in Washington, DC

Retrieved on: 
Wednesday, January 17, 2024

This five-day program will feature the latest advancements in medical toxicology research with numerous opportunities for networking and engagement.

Key Points: 
  • This five-day program will feature the latest advancements in medical toxicology research with numerous opportunities for networking and engagement.
  • Please note that registration for individual symposia is separate from the three-day main meeting.
  • The 2024 ACMT Annual Scientific Meeting main program will initiate on Friday, April 12.
  • Register now for the 2024 ACMT Annual Scientific Meeting and Symposia.

Ansys Launches AVxcelerate Autonomy, Streamlining Development and Validation of ADAS/AV Systems for L2+, L3, and Beyond

Retrieved on: 
Tuesday, December 19, 2023

PITTSBURGH, Dec. 19, 2023 /PRNewswire/ -- Ansys (NASDAQ: ANSS) launches AVxcelerate Autonomy, a first-of-its-kind, end-to-end solution capable of reducing cost and time-to-compliance for L2+, L3, and above ADAS/AV systems by 100,000X. Co-developed with the BMW Group, Ansys AVxcelerate Autonomy empowers companies to further digital transformation efforts and achieve the majority of test driving required for compliance virtually.

Key Points: 
  • Co-developed with the BMW Group , Ansys AVxcelerate Autonomy empowers companies to further digital transformation efforts and achieve the majority of test driving required for compliance virtually.
  • The latest evolution in AV simulation technology, Ansys AVxcelerate Autonomy is cloud-native, modular, and designed around an MBSE framework.
  • Designed for continuous safety validation, AVxcelerate Autonomy can accommodate over-the-air updates for the lifecycle of the product.
  • The predictive accuracy and framework of Ansys AVxcelerate Autonomy can speed autonomous technology development to support the industry in realizing a future where traffic collisions are extinct."

Foretellix Raises $85 Million in Series C Closing

Retrieved on: 
Tuesday, December 5, 2023

TEL-AVIV, Israel and SUNNYVALE, Calif., Dec. 5, 2023 /PRNewswire/ -- Foretellix, the leading provider of safety-driven verification and validation (V&V) solutions for Automated Driving Systems and Advanced Driver Assistance Systems (ADAS), has announced today that it closed a Series C funding round of $85 million, bringing its total raised capital to $135 million. The funding round was led by 83North. The new investors Temasek and Isuzu joined Woven Capital - the growth fund of Toyota - NVIDIA, and Artofin, which participated in the first closing earlier this year. All major existing shareholders participated, including MoreTech, Nationwide, Volvo Group VC, Jump Capital, Next Gear Ventures, and OurCrowd. Foretellix will use the funding to accelerate the development of its expanding product portfolio and address the growing worldwide demand for its solutions.

Key Points: 
  • The new investors Temasek and Isuzu joined Woven Capital - the growth fund of Toyota - NVIDIA, and Artofin, which participated in the first closing earlier this year.
  • Foretellix will use the funding to accelerate the development of its expanding product portfolio and address the growing worldwide demand for its solutions.
  • "We are thrilled to have Temasek and Isuzu join as investors," said Ziv Binyamini, Foretellix CEO and Co-Founder.
  • Foretellix led the ASAM OpenSCENARIO® 2.0 (OSC2.0) standard development, revolutionizing how safety is developed and tested in Automated Driving Systems.

Foretellix Raises $85 Million in Series C Closing

Retrieved on: 
Tuesday, December 5, 2023

TEL-AVIV, Israel and SUNNYVALE, Calif., Dec. 5, 2023 /PRNewswire/ -- Foretellix, the leading provider of safety-driven verification and validation (V&V) solutions for Automated Driving Systems and Advanced Driver Assistance Systems (ADAS), has announced today that it closed a Series C funding round of $85 million, bringing its total raised capital to $135 million. The funding round was led by 83North. The new investors Temasek and Isuzu joined Woven Capital - the growth fund of Toyota - NVIDIA, and Artofin, which participated in the first closing earlier this year. All major existing shareholders participated, including MoreTech, Nationwide, Volvo Group VC, Jump Capital, Next Gear Ventures, and OurCrowd. Foretellix will use the funding to accelerate the development of its expanding product portfolio and address the growing worldwide demand for its solutions.

Key Points: 
  • The new investors Temasek and Isuzu joined Woven Capital - the growth fund of Toyota - NVIDIA, and Artofin, which participated in the first closing earlier this year.
  • Foretellix will use the funding to accelerate the development of its expanding product portfolio and address the growing worldwide demand for its solutions.
  • "We are thrilled to have Temasek and Isuzu join as investors," said Ziv Binyamini, Foretellix CEO and Co-Founder.
  • Foretellix led the ASAM OpenSCENARIO® 2.0 (OSC2.0) standard development, revolutionizing how safety is developed and tested in Automated Driving Systems.

Top Ten Things Physicians and the Public Should Know about Addiction; Resources Developed by Medical Associations Released Today

Retrieved on: 
Thursday, November 2, 2023

The APA’s vision is to ensure access to quality psychiatric diagnosis and treatment.

Key Points: 
  • The APA’s vision is to ensure access to quality psychiatric diagnosis and treatment.
  • Family physicians conduct approximately one in five office visits -- that’s 192 million visits annually or 48 percent more than the next most visited medical specialty.
  • Today, family physicians provide more care for America’s underserved and rural populations than any other medical specialty.
  • ASAM, founded in 1954, is a professional medical society representing over 7,000 physicians, clinicians and associated professionals in the field of addiction medicine.

Lifesaving Platform, Shatterproof Treatment Atlas, Coming to Connecticut to Address the Addiction Crisis

Retrieved on: 
Monday, October 23, 2023

Together, they will announce a new Shatterproof resource that is being offered throughout Connecticut to assist residents with substance use disorders, support those impacted by substance use disorders, and mobilize those in recovery.

Key Points: 
  • Together, they will announce a new Shatterproof resource that is being offered throughout Connecticut to assist residents with substance use disorders, support those impacted by substance use disorders, and mobilize those in recovery.
  • Shatterproof is the leading grassroots organization committed to removing systemic barriers to recovery, mobilizing the country to advocate for change, and ending addiction stigma, and Shatterproof Treatment Atlas is a state-funded project.
  • Treatment Atlas, a lifesaving solution that highlights high-quality addiction treatment options, will become available to help thousands of residents find addiction treatment that will meet their unique needs.
  • The development of the Connecticut section of Treatment Atlas is funded by a grant from DMHAS.

Lifesaving Platform, Shatterproof Treatment Atlas, Coming to Connecticut to Address the Addiction Crisis

Retrieved on: 
Tuesday, October 17, 2023

This National Addiction Treatment Week (October 19-25), the State of Connecticut Department of Mental Health and Addiction Services (DMHAS) Deputy Commissioner Colleen Harrington, LCSW, MBA; Shatterproof Founder and CEO Gary Mendell; and Shatterproof Ambassador Dita Bhargava will unveil a historic lifesaving tool on Tuesday, October 24 at 9 a.m. Eastern.

Key Points: 
  • This National Addiction Treatment Week (October 19-25), the State of Connecticut Department of Mental Health and Addiction Services (DMHAS) Deputy Commissioner Colleen Harrington, LCSW, MBA; Shatterproof Founder and CEO Gary Mendell; and Shatterproof Ambassador Dita Bhargava will unveil a historic lifesaving tool on Tuesday, October 24 at 9 a.m. Eastern.
  • Shatterproof is the leading grassroots organization committed to removing systemic barriers to recovery, mobilizing the country to advocate for change, and ending addiction stigma, and Shatterproof Treatment Atlas is a state-funded project.
  • Treatment Atlas, a lifesaving solution that highlights high-quality addiction treatment options, will become available to help thousands of residents find addiction treatment that will meet their unique needs.
  • The development of the Connecticut section of Treatment Atlas is funded by a grant from DMHAS.

Dow Jones Risk & Compliance Launches RiskCenter Advanced Screening and Monitoring

Retrieved on: 
Tuesday, September 19, 2023

NEW YORK, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Dow Jones Risk & Compliance has today announced a new advanced, AI-powered solution for financial crime and third-party risk management.

Key Points: 
  • NEW YORK, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Dow Jones Risk & Compliance has today announced a new advanced, AI-powered solution for financial crime and third-party risk management.
  • RiskCenter Advanced Screening and Monitoring (ASAM) uses best-in-class risk data, cutting-edge machine learning and AI technologies to optimize anti-money laundering (AML), sanctions and anti-corruption compliance.
  • “As the legislative landscape becomes increasingly complex, organizations need to be able to identify and evaluate risk quickly and effectively,” said Joel Lange, general manager of Risk & Research at Dow Jones.
  • Dow Jones will expand its suite of compliance-ready, AI-powered risk management tools over the next 12 months as it continues to invest in advanced AI, generative AI and automation for the compliance sector.

Lifesaving Platform Coming to Wisconsin to Address the Addiction Crisis

Retrieved on: 
Wednesday, June 21, 2023

Together, they will announce Shatterproof programming that is being offered throughout Wisconsin to assist residents with substance use disorders, support those impacted by substance use disorders, and mobilize those in recovery.

Key Points: 
  • Together, they will announce Shatterproof programming that is being offered throughout Wisconsin to assist residents with substance use disorders, support those impacted by substance use disorders, and mobilize those in recovery.
  • Treatment Atlas, a lifesaving solution that highlights high-quality addiction treatment options, will become available to help thousands of residents find addiction treatment that will meet their unique needs.
  • The development of the Wisconsin section of Treatment Atlas is funded by a grant from the Wisconsin Department of Health Services.
  • Individuals across Wisconsin can use this free-to-the-public, confidential, best-in-class platform to take a user-friendly needs assessment that was developed in collaboration with the American Society for Addiction Medicine (ASAM) and search for care using robust filtering tools.